France· FR:68656947
BUPRENORPHINE/NALOXONE VIATRIS 8 mg/2 mg, comprimé sublingual sécable
A medicinal product containing chlorhydrate de buprénorphine + chlorhydrate de naloxone dihydraté, registered in France by VIATRIS SANTE, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE DE BUPRÉNORPHINE + CHLORHYDRATE DE NALOXONE DIHYDRATÉ
- Manufacturer
- VIATRIS SANTE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip1334009301507027 plaquettes prédécoupées unitaires OPA : polyamide orienté aluminium PVC-Aluminium de 1 compriméEUR 4.67
- cip13340093015072628 plaquettes prédécoupées unitaires OPA : polyamide orienté aluminium PVC-Aluminium de 1 compriméEUR 20.29
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chlorhydrate de buprénorphine + chlorhydrate de naloxone dihydraté in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United Statesbuprenorphine and naloxoneHikma Pharmaceuticals USA Inc.
- CzechiaBUPENSANDUOG.L. Pharma GmbH, Lannach
- United KingdomBuprenorphine 2mg / Naloxone 500microgram sublingual tablets sugar freeDE Pharmaceuticals
- FinlandBunalictSandoz A/S
- SwedenBunalict 2 mg/0,5 mg Resoriblett, sublingualSandoz A/S
- NetherlandsBunalict 2 mg/0,5 mg, tabletten voor sublinguaal gebruikSandoz B.V.
- SpainBUPRENORFINA/NALOXONA AUROVITAS 2 MG/0,5 MG COMPRIMIDOS SUBLINGUALES EFGAurovitas Spain, S.A.U.
- IrelandBulexin 2 mg/0.5 mg sublingual tabletsPinewood Laboratories Limited
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Bupensan Duo
- Belgium · Libroxar
- Bulgaria · Булнексо
- Cyprus · Libroxar
- Czechia · Bupensanduo, Libroxar
- Germany · Bowielone, Bulnexo
- Denmark · Bunalict, Buprenorphin/Naloxon G.L. Pharma
- Estonia · Bupensanduo
- Spain · Buprenorfina/Naloxona Aurovitas
- Finland · Bunalict, Buprenorphine/Naloxone G.L. Pharma
- United Kingdom (Northern Ireland) · Buprenorphine/Naloxone Ethypharm, Buprenorphine/Naloxone G.L. Pharma
- Greece · Libroxar
- Croatia · Bulnexo, Bunalict
- Hungary · Bulnexo
- Ireland · Bulexin, Buprenorphine/Naloxone Pinewood
- Iceland · Suboxone, Zubsolv
- Italy · Bunamol, Buprenorfina E Naloxone Ethypharm
- Liechtenstein · Suboxone, Zubsolv
- Lithuania · Bupensanduo
- Luxembourg · Libroxar
- Latvia · Bupensanduo
- Malta · Libroxar
- Netherlands · Bunalict, Buprenorfine/Naloxon Viatris
- Norway · Bunalict, Suboxone
- Portugal · Buprenorfina + Naloxona Generis
- Sweden · Bunalict, Buprenorphine/Naloxone G.L. Pharma
- Slovenia · Bulnexo
- Slovakia · Bupensanduo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/327cc4d9-35a5-4ff7-97bc-5fe2b4e7696d GET /v1/drugs/327cc4d9-35a5-4ff7-97bc-5fe2b4e7696d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "68656947",
"date_amm": "2018-06-13",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "CHLORHYDRATE DE BUPRÉNORPHINE + CHLORHYDRATE DE NALOXONE DIHYDRATÉ",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé sécable",
"voies_administration": "sublinguale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about chlorhydrate de buprénorphine + chlorhydrate de naloxone dihydraté.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.